Skip to main content

Table 2 Clinical and interventions comparison between CRT responders at T2, according to study group

From: A lactate-targeted resuscitation strategy may be associated with higher mortality in patients with septic shock and normal capillary refill time: a post hoc analysis of the ANDROMEDA-SHOCK study

Original study arm

CRT Normal at 2 h (n = 184)

P

CRT

Lactate

Number of patients

102 (55)

82 (45)

 

Age (years)

62 [46–72]

65 [49–74]

0.23

Sex

Female 49 (48)

Female 39 (48)

0.90

Male 53 (52)

Male 43 (52)

APACHE II score

20 [14–26]

19 [16–24]

0.96

SOFA score

9 [7–11]

9 [7–11]

0.63

Charlson Index

3 [1–5]

3 [1–5]

0.76

Sepsis origin n (%)

Urinary 17 (17)

Urinary 20 (24)

0.36

Pulmonary 37 (36)

Pulmonary 18 (22)

Abdominal 33 (33)

Abdominal 31 (37)

Other 14 (14)

Other 14 (17)

MAP (mmHg)

70 [65–83]

67 [62–75]

0.01

CVP (mmHg)

9 [6–13]

9 [5–14]

0.70

Pre-protocol fluids (ml)

2000 [1238–2850]

2050 [1500–2957]

0.15

NE dose (mcg/kg/min)

0.18 [0.1–0.31]

0.15 [0.1–0.3]

0.60

Baseline lactate (mmol/L)

3.3 [2.6–4.4]

3.2 [2.7–4.3]

0.73

Baseline CRT (s)

4 [2–5]

3 [2–4]

0.15

Baseline mottling score

0 [0–1]

0 [0–1]

0.60

Baseline ScvO2 (%)

74 [68–79]

71 [62–80]

0.40

Baseline dCO2(v-a)

7 [4–9]

7 [5–10]

0.70

Fluid bolus 0–8 h (ml)

500 [0–1500]

1000 [500–2000]

0.004

Fluid balance 8 h (ml)

1090 [319–2000]

1360 [559–2401]

0.038

Vasopressor test

19 (19)

35 (43)

0.001

Inodilator test

3 (3)

13 (16)

0.003

Resuscitative interventions

1.25 [0.5–3]

3 [1.8–4.2]

0.001

SOFA 24 h

7 [4–10]

8 [5–11]

0.11

dSOFA 0-24 h

2 [0–4]

1 [−1–3]

0.004

RRT

11 (11)

16 (19)

0.1

MV

66 (65)

57 (70)

0.50

ICU length of stay (days)

6 [3–12]

6 [3–11]

0.60

28-day mortality

23 (23)

33 (40)

0.009

  1. Data are presented as median [IQR 25–75] or count (percentage)
  2. CRT capillary refill time, APACHE II Acute Physiology And Chronic Health Evaluation II, SOFA Sequential organ failure Assessment score, ICU intensive care unit, MAP mean arterial pressure, CVP central venous pressure, NE norepinephrine, ScvO2 central venous oxygen saturation, Delta pCO2(v-a) difference between central venous carbon dioxide pressure and arterial carbon dioxide pressure, dSOFA delta SOFA, RRT renal replacement therapy, MV mechanical ventilation